49591-052Level 3
HepaGam B (HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN)
**Product type:** Plasma Derivative
**Active ingredient:** HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
**Strength:** 312 [iU]/mL
**Dosage form:** Injection, Solution
**Route:** Intramuscular; Intravenous
**Labeler:** Kamada Ltd.
**Marketing category:** BLA (BLA125035)
**Pharmacologic class:** Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]
GET
/api/v1/systems/ndc_fda/nodes/49591-052Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.